JPS4985066A - - Google Patents

Info

Publication number
JPS4985066A
JPS4985066A JP48090450A JP9045073A JPS4985066A JP S4985066 A JPS4985066 A JP S4985066A JP 48090450 A JP48090450 A JP 48090450A JP 9045073 A JP9045073 A JP 9045073A JP S4985066 A JPS4985066 A JP S4985066A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP48090450A
Other languages
Japanese (ja)
Other versions
JPS59508B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4985066A publication Critical patent/JPS4985066A/ja
Publication of JPS59508B2 publication Critical patent/JPS59508B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96Sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/10Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B31/00Disazo and polyazo dyes of the type A->B->C, A->B->C->D, or the like, prepared by diazotising and coupling
    • C09B31/02Disazo dyes
    • C09B31/12Disazo dyes from other coupling components "C"
    • C09B31/14Heterocyclic components

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP48090450A 1972-08-12 1973-08-11 ノウケツカンカクチヨウザイ 2 3− チカン −4− フクソカンジヨウアミノスルホニルベンゼンスルホンアミド ノ セイホウ Expired JPS59508B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3772072A GB1380009A (en) 1972-08-12 1972-08-12 Cyclic derivatives of 1,4-benzene disulphonamide

Publications (2)

Publication Number Publication Date
JPS4985066A true JPS4985066A (enExample) 1974-08-15
JPS59508B2 JPS59508B2 (ja) 1984-01-07

Family

ID=10398552

Family Applications (2)

Application Number Title Priority Date Filing Date
JP48090450A Expired JPS59508B2 (ja) 1972-08-12 1973-08-11 ノウケツカンカクチヨウザイ 2 3− チカン −4− フクソカンジヨウアミノスルホニルベンゼンスルホンアミド ノ セイホウ
JP56116291A Expired JPS5857431B2 (ja) 1972-08-12 1981-07-24 脳血管拡張剤2,3−置換−4−複素環状アミノスルホニルベンゼンスルホンアミドの製法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP56116291A Expired JPS5857431B2 (ja) 1972-08-12 1981-07-24 脳血管拡張剤2,3−置換−4−複素環状アミノスルホニルベンゼンスルホンアミドの製法

Country Status (16)

Country Link
US (1) US3867390A (enExample)
JP (2) JPS59508B2 (enExample)
AT (1) AT331248B (enExample)
AU (1) AU5908473A (enExample)
BE (1) BE803373A (enExample)
CA (1) CA978945A (enExample)
DE (1) DE2340010A1 (enExample)
ES (1) ES417806A1 (enExample)
FR (1) FR2195449B1 (enExample)
GB (1) GB1380009A (enExample)
IE (1) IE38177B1 (enExample)
IN (1) IN139006B (enExample)
LU (1) LU68211A1 (enExample)
NL (1) NL162641C (enExample)
SE (1) SE385008B (enExample)
ZA (1) ZA735474B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070361A (en) * 1977-04-21 1978-01-24 E. R. Squibb & Sons, Inc. Mercaptoalkylsulfonyl proline and pipecolic acid and esters thereof
DE2720654A1 (de) * 1977-05-07 1978-11-16 Bayer Ag Azolyl-alkancarbonsaeure-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
JPS5922023A (ja) * 1982-07-27 1984-02-04 Hoya Corp ビ−ムスプリツタ−

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3165550A (en) * 1960-06-29 1965-01-12 Pfizer & Co C N-substituted p-benzenedisulfonamides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3165550A (en) * 1960-06-29 1965-01-12 Pfizer & Co C N-substituted p-benzenedisulfonamides

Also Published As

Publication number Publication date
US3867390A (en) 1975-02-18
AT331248B (de) 1976-08-10
IE38177L (en) 1974-02-12
JPS5857431B2 (ja) 1983-12-20
NL162641B (nl) 1980-01-15
IE38177B1 (en) 1978-01-18
LU68211A1 (enExample) 1975-05-21
CA978945A (en) 1975-12-02
GB1380009A (en) 1975-01-08
NL7311000A (enExample) 1974-02-14
IN139006B (enExample) 1976-04-24
JPS59508B2 (ja) 1984-01-07
SE385008B (sv) 1976-05-31
BE803373A (fr) 1974-02-08
ATA691573A (de) 1975-11-15
AU5908473A (en) 1975-02-13
FR2195449B1 (enExample) 1977-09-09
ZA735474B (en) 1974-08-28
FR2195449A1 (enExample) 1974-03-08
DE2340010A1 (de) 1974-03-14
JPS57131774A (en) 1982-08-14
ES417806A1 (es) 1976-03-01
NL162641C (nl) 1980-06-16

Similar Documents

Publication Publication Date Title
JPS4965226A (enExample)
FR2195449B1 (enExample)
CS155480B1 (enExample)
JPS48104493A (enExample)
JPS5512601B2 (enExample)
JPS5312039Y2 (enExample)
JPS4932762U (enExample)
JPS514854B1 (enExample)
CS156365B1 (enExample)
CS151679B1 (enExample)
CS151398B1 (enExample)
CS151836B1 (enExample)
CS153941B1 (enExample)
JPS4932976A (enExample)
CS154549B1 (enExample)
CS155039B3 (enExample)
JPS4920299U (enExample)
CS155439B1 (enExample)
JPS49108252U (enExample)
JPS4974928A (enExample)
CS155994B2 (enExample)
CS156375B1 (enExample)
CS152035B1 (enExample)
CS156350B1 (enExample)
CS156360B1 (enExample)

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees
S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R370 Written measure of declining of transfer procedure

Free format text: JAPANESE INTERMEDIATE CODE: R370